mci 9038 has been researched along with Mesenteric Vascular Occlusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senoh, M; Sunami, K; Yokota, Y; Yoshioka, T | 1 |
| Eto, T; Gondo, H; Hamasaki, N; Ichimiya, H; Kato, K; Kawamoto, M; Kayamori, Y; Muta, T; Okamura, T; Shibuya, T; Urata, M; Wada, Y; Yamanaka, M | 1 |
2 other study(ies) available for mci 9038 and Mesenteric Vascular Occlusion
| Article | Year |
|---|---|
Successful intravenous administration of argatroban in the management of heparin-resistant and surgery-resistant mesenteric vein thrombosis.
Topics: Administration, Intravenous; Aged; Antithrombins; Arginine; Female; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Portal Vein; Splenic Vein; Sulfonamides; Treatment Outcome; Venous Thrombosis | 2019 |
Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency.
Topics: Adult; Antithrombin III Deficiency; Arginine; DNA Mutational Analysis; Female; Frameshift Mutation; Heterozygote; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Salvage Therapy; Sulfonamides; Treatment Outcome; Venous Thrombosis | 2005 |